Hsbc Holdings PLC Infinity Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $6,420 - $18,499	-10,882 Reduced 41.66%	15,241 $18,000
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $13,169 - $17,179	4,951 Added 23.38%	26,123 $78,000
Q1 2021 May 14, 2021	BUY	$1.98 - $5.36 $41,920 - $113,481	21,172 New	21,172 $68,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.